当前位置: 首页 SCI期刊 SCIE期刊 JCRQ3 期刊介绍(非官网)
Antibodies

AntibodiesSCIE

国际简称:ANTIBODIES  参考译名:抗体

  • CiteScore分区

    Q2

  • JCR分区

    Q3

基本信息:
ISSN:2073-4468
是否OA:开放
是否预警:否
出版信息:
出版地区:Switzerland
出版商:MDPI AG
出版语言:English
研究方向:IMMUNOLOGY
评价信息:
影响因子:3
CiteScore指数:7.1
SJR指数:1.12
SNIP指数:0.9
发文数据:
Gold OA文章占比:99.01%
研究类文章占比:61.25%
年发文量:80
英文简介 期刊介绍 CiteScore数据 JCR分区 常见问题

英文简介Antibodies期刊介绍

Antibodies is an international open access journal focused on the field of antibody science, published by MDPI Press. This journal covers the structure, function, production, application, and related immunological research of antibodies. It aims to promote basic and applied research in antibody science, including the latest developments in antibody engineering, immunotherapy, vaccine development, and more. The content of journals not only includes original research papers, but also systematic reviews and comprehensive analytical articles. The journal adopts a single blind peer review system to ensure that the published research has high academic standards and innovation. In addition, the journal emphasizes a fast publishing process to accelerate the dissemination of scientific research results.

The journal is included in multiple databases, including Scopus, ESCI, PubMed, PMC, EMBASE, and Chemical Abstracts, further demonstrating its recognition and visibility in the academic community. The editorial and review teams of the journal are composed of internationally renowned scientists who work together to maintain the academic quality and international perspective of the issue. It is an important platform for antibody science researchers and related professionals to publish and obtain high-quality research results.

期刊简介Antibodies期刊介绍

《Antibodies》该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

  • 预计审稿时间: 11 Weeks
  • SCIE
  • 非预警

Cite Score数据(2024年最新版)Antibodies Cite Score数据

  • CiteScore:7.1
  • SJR:1.115
  • SNIP:0.903
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q2 46 / 157

71%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Immunology and Allergy Q2 79 / 233

66%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Immunology Q2 95 / 236

59%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

JCR分区Antibodies JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY ESCI Q3 105 / 181

42.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY ESCI Q3 121 / 181

33.43%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

投稿常见问题